AU (Australia) Breast Lift

Breast Lift Related Terms:
Breast Lift In AU Australia, AU Body Procedures, AU Boobs Job, AU Boobs Lift, AU Bosom Lift, AU Breast, AU Breast Augmentation, AU Breast Enlargement, AU Breast Enlargement, AU Breast Implants, AU Breast Lift, AU Breast Lift Crescent Incision, AU Breast Lift Doughnut Incision, AU Breast Lift T Incision, AU Breast Lift Vertical Incision, AU Breast Procedures, AU Breast Up Lift, AU Capsular Contracture, AU Chest, AU Cosmetic Surgery, AU Mastopexy, AU Non Surgical Breast Lift, AU Plastic Surgery, AU Saline Breast Implants Areola Incision, AU Saline Breast Implants Armpit Incision, AU Saline Breast Implants Under The Breast Incision, AU Silicone Breast Implants Areola Incision, AU Silicone Breast Implants Armpit Incision, AU Silicone Breast Implants Under The Breast Incision

Breast Lift in AU section, includes general infrmation about Breast Lift Procedure, Breast Lift AU Local News, Breast Lift AU Surgeon Locator and other Breast Lift related material.

AU breast lift - Tip of the day:

What is Breast Lift?
It is a cosmetic surgery procedure offered in AU(Australia) meant to enhance the shape and increase the size of a woman’s breasts. It is meant to produce fuller breasts after surgery in AU(Australia) addressing sagging breasts as a woman ages. It also enhances women who have flat breasts dictated by their genetic make-up.

Breast Lift Procedure

A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).

AU breast lift - News update:
Three-year results reported from a controlled trial of etanercept plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) confirm the continued efficacy of the combination against monotherapy, with no unexpected adverse effects. The TEMPO trial was planned from outset as a longer-term, three-year study. It compared etanercept plus MTX against either drug as monotherapy in adult patients with active RA not responding to at least one previous DMARD other than MTX. They were randomised to double-blind treatment with etanercept, MTX, or the combination; initial outcomes focussed on response to treatment using ACR criteria. For the long-term phase, the outcomes used were disease activity and remission using the Disease Activity Score (DAS); response according the ACR score was also assessed. The authors used statistical techniques that attempted to correct for biases inherent in long-term therapeutic trials. TEMPO initially randomised 686 patients, of whom 682 received at least one dose of study drug. Over the three years, 350 patients withdrew from the trial, with more withdrawals due to inefficacy in the monotherapy groups (combination group 5% vs. 16% for etanercept and 17% for MTX). Analysis indicated that those in the combination therapy group had greater improvement in DAS and were more likely to remain in remission than those in either monotherapy group. Patients in the combination group did better than those in the monotherapy groups on most other outcomes; the combination and etanercept were both better than MTX alone for radiographic progression. Adverse effects were similar across the three groups, and no new or unexpected adverse effects were reported in year three. Overall, the authors conclude that etanercept plus MTX combination treatment continued to show superior efficacy to monotherapy over three years, even after adjustment for withdrawals. There were no additional safety concerns. More...